Home » Topics » Regulatory

Regulatory
RSS

Clinical trials begin for chronic hepatitis C agent, Alferon N Injection

July 12, 1996

Bristol-Myers Squibb's Pravachol cleared by FDA for new indication

July 12, 1996

First approval of SmithKline Beecham's ReQuip in U.K.

July 12, 1996

CEA-Scan cleared for market by FDA

July 12, 1996

New formulaton of Videx launched in Canada

July 12, 1996

Ketotifen shown effective in NSAID-induced ulcer model

July 5, 1996

New beclomethasone formulation cleared for marketing

July 5, 1996

New Iomeron formulation introduced in Japan

July 5, 1996

Low-dose lovastatin + niacin shows good efficacy and safety in patient study

July 5, 1996

Prosorba trial initiated in arthritis sufferers

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...